| Issue Date | Title | Author(s) |
| 24-Jun-2017 | Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase | Gupta, A; Thompson, D; Whitehouse, A; Collier, T; Dahlof, B, et al |
| 1-May-2016 | Assessment of hemodynamic conditions in the aorta following root replacement with composite valve-conduit graft | Cheng, Z; Kidher, E; Jarral, OA; O'Regan, DP; Wood, NB, et al |
| 1-Jul-2019 | Association of nonfasting vs fasting lipid levels with risk of major coronary events in the Anglo-Scandinavian cardiac outcomes trial-lipid lowering arm | Mora, S; Chang, CL; Moorthy, MV; Sever, PS; , et al |
| Jun-2013 | Brachial pressure waveforms: measuring and modelling | Siggers, Jennifer; Parker, Kim; Hughes, Alun; Davies, Justin; Korolkova, Olga, et al |
| - | His resynchronization versus biventricular pacing in patients with heart failure and left bundle branch block | Arnold, A; Shun-Shin, M; Keene, D; Howard, J; Sohaib, S, et al |
| Sep-2019 | How to deliver personalized Cardiac Resynchronization Therapy through the precise measurement of the acute hemodynamic response: insights from the iSpot trial | Shun‐Shin, MJ; Miyazawa, AA; Keene, D; Sterliński, M; Sokal, A, et al |
| 7-Jun-2017 | Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials | Shun-Shin, MJ; Zheng, S; Cole, G; Howard, J; Whinnett, Z, et al |
| Jun-2017 | Investigating the roles of peripheral and central blood pressure and blood pressure variability on the size and growth rate of AAAs in the AARDVARK trial and the CAVE sub-study | Poulter, Professor Neil; Bicknell, Mr Colin; Kiru, Gayithri; |
| 1-May-2019 | Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC) | Rahimi, K; Canoy, D; Nazarzadeh, M; Salimi-Khorshidi, G; Woodward, M, et al |
| 29-Jan-2019 | Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure | Ferreira, JP; Rossignol, P; Pizard, A; Machu, J-L; Collier, T, et al |
| Jun-2019 | Quantification of Electromechanical Coupling to Prevent Inappropriate Implantable Cardioverter-Defibrillator Shocks | Keene, D; Shun-Shin, M; Arnold, A; Howard, J; Lefroy, D, et al |
| 15-Jan-2017 | Resonance as the mechanism of daytime periodic breathing in patients with heart failure | Sands, SA; Mebrate, Y; Edwards, BA; Nernati, S; Manisty, CH, et al |
| 1-Oct-2019 | Right ventricular pacing for hypertrophic obstructive cardiomyopathy: meta-analysis and meta-regression of clinical trials | Arnold, A; Howard, J; Chiew, K; Kerrigan, W; De Vere, F, et al |
| 6-Sep-2017 | Serum chloride and adverse cardiovascular events in the Anglo Scandinavian Cardiac Outcomes Trial (ASCOT) | McCallum, L; Welsh, P; Sever, P; Sattar, N; Padmanabhan, S, et al |